BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Granata V, Grassi R, Fusco R, Setola SV, Palaia R, Belli A, Miele V, Brunese L, Petrillo A, Izzo F. Assessment of Ablation Therapy in Pancreatic Cancer: The Radiologist's Challenge. Front Oncol. 2020;10:560952. [PMID: 33330028 DOI: 10.3389/fonc.2020.560952] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Granata V, Fusco R, Setola SV, Galdiero R, Maggialetti N, Patrone R, Ottaiano A, Nasti G, Silvestro L, Cassata A, Grassi F, Avallone A, Izzo F, Petrillo A. Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics. Infect Agent Cancer 2023;18:18. [PMID: 36927442 DOI: 10.1186/s13027-023-00495-x] [Reference Citation Analysis]
2 Martin RCG 2nd, Schoen EC, Philips P, Egger ME, McMasters KM, Scoggins CR. Impact of margin accentuation with intraoperative irreversible electroporation on local recurrence in resected pancreatic cancer. Surgery 2023;173:581-9. [PMID: 36216618 DOI: 10.1016/j.surg.2022.07.033] [Reference Citation Analysis]
3 Flammia F, Innocenti T, Galluzzo A, Danti G, Chiti G, Grazzini G, Bettarini S, Tortoli P, Busoni S, Dragoni G, Gottin M, Galli A, Miele V. Branch duct-intraductal papillary mucinous neoplasms (BD-IPMNs): an MRI-based radiomic model to determine the malignant degeneration potential. Radiol Med 2023. [PMID: 36826452 DOI: 10.1007/s11547-023-01609-6] [Reference Citation Analysis]
4 Grassi F, Granata V, Fusco R, De Muzio F, Cutolo C, Gabelloni M, Borgheresi A, Danti G, Picone C, Giovagnoni A, Miele V, Gandolfo N, Barile A, Nardone V, Grassi R. Radiation Recall Pneumonitis: The Open Challenge in Differential Diagnosis of Pneumonia Induced by Oncological Treatments. J Clin Med 2023;12. [PMID: 36835977 DOI: 10.3390/jcm12041442] [Reference Citation Analysis]
5 Granata V, Fusco R, De Muzio F, Cutolo C, Grassi F, Brunese MC, Simonetti I, Catalano O, Gabelloni M, Pradella S, Danti G, Flammia F, Borgheresi A, Agostini A, Bruno F, Palumbo P, Ottaiano A, Izzo F, Giovagnoni A, Barile A, Gandolfo N, Miele V. Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence. Biology (Basel) 2023;12. [PMID: 36829492 DOI: 10.3390/biology12020213] [Reference Citation Analysis]
6 Granata V, Fusco R, Setola SV, Simonetti I, Picone C, Simeone E, Festino L, Vanella V, Vitale MG, Montanino A, Morabito A, Izzo F, Ascierto PA, Petrillo A. Immunotherapy Assessment: A New Paradigm for Radiologists. Diagnostics (Basel) 2023;13. [PMID: 36673112 DOI: 10.3390/diagnostics13020302] [Reference Citation Analysis]
7 Cutolo C, Fusco R, Simonetti I, De Muzio F, Grassi F, Trovato P, Palumbo P, Bruno F, Maggialetti N, Borgheresi A, Bruno A, Chiti G, Bicci E, Brunese MC, Giovagnoni A, Miele V, Barile A, Izzo F, Granata V. Imaging Features of Main Hepatic Resections: The Radiologist Challenging. J Pers Med 2023;13. [PMID: 36675795 DOI: 10.3390/jpm13010134] [Reference Citation Analysis]
8 Granata V, Fusco R, Setola SV, Galdiero R, Maggialetti N, Silvestro L, De Bellis M, Di Girolamo E, Grazzini G, Chiti G, Brunese MC, Belli A, Patrone R, Palaia R, Avallone A, Petrillo A, Izzo F. Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence. Cancers (Basel) 2023;15. [PMID: 36672301 DOI: 10.3390/cancers15020351] [Reference Citation Analysis]
9 Nardini M, Capotosti A, Mazzoni LN, Cusumano D, Boldrini L, Chiloiro G, Romano A, Valentini V, Indovina L, Placidi L. Tuning the optimal diffusion-weighted MRI parameters on a 0.35-T MR-Linac for clinical implementation: A phantom study. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.867792] [Reference Citation Analysis]
10 Shen J, Pan P, Hu X, Zhao J, Wu H. Safety and Efficacy of Irreversible Electroporation in Locally Advanced Pancreatic Cancer: An Evaluation from a Surgeon's Perspective. Cancers (Basel) 2022;14. [PMID: 36428767 DOI: 10.3390/cancers14225677] [Reference Citation Analysis]
11 Tasu J, Tougeron D, Rols M. Irreversible electroporation and electrochemotherapy in oncology: State of the art. Diagnostic and Interventional Imaging 2022;103:499-509. [DOI: 10.1016/j.diii.2022.09.009] [Reference Citation Analysis]
12 Bazeed AY, Day CM, Garg S. Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies. Cancers 2022;14:4257. [DOI: 10.3390/cancers14174257] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Granata V, De Muzio F, Cutolo C, Dell’aversana F, Grassi F, Grassi R, Simonetti I, Bruno F, Palumbo P, Chiti G, Danti G, Fusco R. Structured Reporting in Radiological Settings: Pitfalls and Perspectives. JPM 2022;12:1344. [DOI: 10.3390/jpm12081344] [Reference Citation Analysis]
14 Granata V, Simonetti I, Fusco R, Setola SV, Izzo F, Scarpato L, Vanella V, Festino L, Simeone E, Ascierto PA, Petrillo A. Management of cutaneous melanoma: radiologists challenging and risk assessment. Radiol med 2022;127:899-911. [DOI: 10.1007/s11547-022-01522-4] [Reference Citation Analysis]
15 Simonetti I, Bruno F, Fusco R, Cutolo C, Setola SV, Patrone R, Masciocchi C, Palumbo P, Arrigoni F, Picone C, Belli A, Grassi R, Grassi F, Barile A, Izzo F, Petrillo A, Granata V. Multimodality Imaging Assessment of Desmoid Tumors: The Great Mime in the Era of Multidisciplinary Teams. JPM 2022;12:1153. [DOI: 10.3390/jpm12071153] [Reference Citation Analysis]
16 Granata V, Fusco R, Belli A, Danti G, Bicci E, Cutolo C, Petrillo A, Izzo F. Diffusion weighted imaging and diffusion kurtosis imaging in abdominal oncological setting: why and when. Infect Agent Cancer 2022;17:25. [PMID: 35681237 DOI: 10.1186/s13027-022-00441-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Mansur A, Garg T, Shrigiriwar A, Etezadi V, Georgiades C, Habibollahi P, Huber TC, Camacho JC, Nour SG, Sag AA, Prologo JD, Nezami N. Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors. Diagnostics 2022;12:1300. [DOI: 10.3390/diagnostics12061300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 De Muzio F, Cutolo C, Dell'Aversana F, Grassi F, Ravo L, Ferrante M, Danti G, Flammia F, Simonetti I, Palumbo P, Bruno F, Pierpaoli L, Fusco R, Giovagnoni A, Miele V, Barile A, Granata V. Complications after Thermal Ablation of Hepatocellular Carcinoma and Liver Metastases: Imaging Findings. Diagnostics (Basel) 2022;12. [PMID: 35626306 DOI: 10.3390/diagnostics12051151] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
19 Granata V, Fusco R, Belli A, Borzillo V, Palumbo P, Bruno F, Grassi R, Ottaiano A, Nasti G, Pilone V, Petrillo A, Izzo F. Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma. Infect Agents Cancer 2022;17. [DOI: 10.1186/s13027-022-00429-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Granata V, Morana G, D'Onofrio M, Fusco R, Coppola F, Grassi F, Cappabianca S, Reginelli A, Maggialetti N, Buccicardi D, Barile A, Rengo M, Bortolotto C, Urraro F, La Casella GV, Montella M, Ciaghi E, Bellifemine F, De Muzio F, Danti G, Grazzini G, Barresi C, Brunese L, Neri E, Grassi R, Miele V, Faggioni L. Structured Reporting of Computed Tomography and Magnetic Resonance in the Staging of Pancreatic Adenocarcinoma: A Delphi Consensus Proposal. Diagnostics (Basel) 2021;11:2033. [PMID: 34829384 DOI: 10.3390/diagnostics11112033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Haroon M, Sathiadoss P, Hibbert RM, Jeyaraj SK, Lim C, Schieda N. Imaging considerations for thermal and radiotherapy ablation of primary and metastatic renal cell carcinoma. Abdom Radiol (NY) 2021;46:5386-407. [PMID: 34245341 DOI: 10.1007/s00261-021-03178-6] [Reference Citation Analysis]
22 Wu Y, Gu Y, Zhang B, Zhou X, Li Y, Qian Z. Laparoscopic ultrasonography-guided cryoablation of locally advanced pancreatic cancer: a preliminary report. Jpn J Radiol 2021. [PMID: 34279799 DOI: 10.1007/s11604-021-01175-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Granata V, Grassi R, Fusco R, Belli A, Cutolo C, Pradella S, Grazzini G, La Porta M, Brunese MC, De Muzio F, Ottaiano A, Avallone A, Izzo F, Petrillo A. Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma. Infect Agent Cancer 2021;16:53. [PMID: 34281580 DOI: 10.1186/s13027-021-00393-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
24 Granata V, Grassi R, Fusco R, Belli A, Palaia R, Carrafiello G, Miele V, Grassi R, Petrillo A, Izzo F. Local ablation of pancreatic tumors: State of the art and future perspectives. World J Gastroenterol 2021; 27(23): 3413-3428 [PMID: 34163121 DOI: 10.3748/wjg.v27.i23.3413] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
25 Flak RV, Fisker RV, Bruun NH, Stender MT, Thorlacius-Ussing O, Petersen LJ. Usefulness of Imaging Response Assessment after Irreversible Electroporation of Localized Pancreatic Cancer-Results from a Prospective Cohort. Cancers (Basel) 2021;13:2862. [PMID: 34201272 DOI: 10.3390/cancers13122862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Granata V, Fusco R, Salati S, Petrillo A, Di Bernardo E, Grassi R, Palaia R, Danti G, La Porta M, Cadossi M, Gašljević G, Sersa G, Izzo F. A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response. Int J Environ Res Public Health 2021;18:5592. [PMID: 34073865 DOI: 10.3390/ijerph18115592] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Granata V, Grassi R, Fusco R, Setola SV, Belli A, Piccirillo M, Pradella S, Giordano M, Cappabianca S, Brunese L, Grassi R, Petrillo A, Izzo F. Abbreviated MRI Protocol for the Assessment of Ablated Area in HCC Patients. Int J Environ Res Public Health 2021;18:3598. [PMID: 33808466 DOI: 10.3390/ijerph18073598] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]